DIPEXIUM PHARMACEUTICALS INC - COM (DPRX)

CUSIP: 25456J104

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
2,657,331
Share change
+83,056
Total reported value
$38,529,175
Price per share
$14.50
Number of holders
32
Value change
+$1,730,558
Number of buys
20
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 25456J104?
CUSIP 25456J104 identifies DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) as of Q3 2016

As of 30 Sep 2016, DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,657,331 shares. The largest 10 holders included KINGDON CAPITAL MANAGEMENT, L.L.C., Tourbillon Capital Partners, L.P., 683 Capital Management, LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, Lone Star Value Management LLC, Lombard Odier Asset Management (USA) Corp, Emerald Acquisition Ltd., Timpani Capital Management LLC, and RAYMOND JAMES & ASSOCIATES. This page lists 32 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.